Tuesday's Democratic presidential debate, the first of 2 days, included disagreements over the viability of Medicare for All; 3 insulin makers received subpoenas from the New York Attorney General over their pricing practices; US News & Report released its 30th Annual Best Hospitals rankings.
While Senators Bernie Sanders, I-Vermont, and Elizabeth Warren, D-Massachusetts, defended Medicare for all during the second round of Democratic presidential debates, other candidates strayed away from supporting the plan, reported Politico. Both Sanders and Warren called universal coverage a moral obligation. However, other candidates warned that the system would force people off of private coverage. Former Colorado Governor John Hickenlooper and current Montana Governor Steve Bullock called Medicare for all an unsustainable government-run system that would negatively impact hospitals and the healthcare industry.
The New York Attorney General has issued subpoenas to insulin makers Sanofi, Eli Lilly, and Novo Nordisk, inquiring about their pricing practices. According to STAT, the subpoenas seek various documents regarding pricing, discount programs, sales and expenses, contracting, marketing materials, and legal proceedings. Spokespeople from Sanofi and Eli Lilly said that the companies are cooperating and a spokeswoman from Novo Nordisk said “this is a matter we take extremely seriously,” reported STAT.
US News & Report has announced its 30th Annual Best Hospital Rankings for 2019-2020. Mayo Clinic came out on top as the best hospital in the country while the University of Texas MD Anderson Cancer Center once again was named the top cancer center. The Cleveland Clinic came in at number 4 on the best hospital list and topped the list for best hospital for cardiology and heart surgery. This year, the rankings included 2 additional patient-centered measures: patient experience score and an outcome measure looking at how often patients go directly home from the hospital rather than transitioning to a nursing home or other care setting.
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage
May 7th 2024Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.
Read More